John Gill, Director at Altimmune, Inc. (ALT), sold 2,714 shares at $15.00 ($41K) on 2022-08-12, disclosed to the SEC on 2023-07-06.
Open-market sale of $41k ALT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALT | SELL | 2020-12-02 | $100K | — | Filing → |
| ALT | BUY | 2017-06-06 | $4K | — | Filing → |